- Home
- PODC vs IGC Comparison
PODC vs IGC Comparison
Compare PODC & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODC
- IGC
- Stock Information
- Founded
- PODC 2013
- IGC 2005
- Country
- PODC United States
- IGC United States
- Employees
- PODC N/A
- IGC N/A
- Industry
- PODC
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- PODC
- IGC Health Care
- Exchange
- PODC Nasdaq
- IGC Nasdaq
- Market Cap
- PODC 39.6M
- IGC 39.8M
- IPO Year
- PODC N/A
- IGC N/A
- Fundamental
- Price
- PODC $1.70
- IGC $0.42
- Analyst Decision
- PODC
- IGC Strong Buy
- Analyst Count
- PODC 0
- IGC 2
- Target Price
- PODC N/A
- IGC $4.00
- AVG Volume (30 Days)
- PODC 70.8K
- IGC 1.4M
- Earning Date
- PODC 11-06-2025
- IGC 08-14-2025
- Dividend Yield
- PODC N/A
- IGC N/A
- EPS Growth
- PODC N/A
- IGC N/A
- EPS
- PODC N/A
- IGC N/A
- Revenue
- PODC $53,954,000.00
- IGC $1,327,000.00
- Revenue This Year
- PODC $17.91
- IGC $15.26
- Revenue Next Year
- PODC $14.41
- IGC $3.41
- P/E Ratio
- PODC N/A
- IGC N/A
- Revenue Growth
- PODC 17.74
- IGC 24.95
- 52 Week Low
- PODC $1.10
- IGC $0.25
- 52 Week High
- PODC $2.94
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- PODC 51.61
- IGC 54.00
- Support Level
- PODC $1.50
- IGC $0.39
- Resistance Level
- PODC $1.60
- IGC $0.47
- Average True Range (ATR)
- PODC 0.13
- IGC 0.04
- MACD
- PODC 0.03
- IGC 0.00
- Stochastic Oscillator
- PODC 73.96
- IGC 41.00
About PODC PodcastOne Inc.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.